Related Experiment Video
Updated: Jun 8, 2026
08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
The internet for self-diagnosis and prognostication in ALS
Zhongbo Chen1, Martin R Turner
1Oxford University Medical School, John Radcliffe Hospital, Oxford, UK.
Summary
Internet searches for Amyotrophic Lateral Sclerosis (ALS) symptoms lack sensitivity, providing varied and sometimes misleading information on prognosis and cures. Reliable online resources are needed to guide patients and families.
Area of Science:
- Neurology
- Medical Informatics
Background:
- Patients with Amyotrophic Lateral Sclerosis (ALS) and their families frequently use the internet for information.
- Online searches are utilized for understanding symptoms, diagnosis, prognosis, and treatment of ALS.
Purpose of the Study:
- To evaluate the sensitivity of internet search engines for ALS symptom-related queries.
- To assess the accuracy of online information regarding ALS prognosis and potential cures.
Main Methods:
- Utilized an internet search engine to test various symptom-related search terms for ALS diagnosis.
- Analyzed search engine responses to queries about ALS life expectancy and cures.
Main Results:
- Internet search engine sensitivity for ALS diagnosis is currently lacking.
- Minor variations in search terms significantly altered search results.
- Prognostic information online did not account for the heterogeneity of ALS.
- Information regarding ALS cures was misleading and potentially created false hope.
Conclusions:
- There is a critical need for improved online resources for individuals with ALS.
- Guiding patients and their families to reliable web-based information is essential.
- Open communication alongside trustworthy online resources is recommended for ALS patient support.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:17Introduction to Language of Pathophysiology ll
This lesson explores key terms that describe how diseases progress, their outcomes, and their distribution in populations.Diagnostic tests identify diseases and monitor treatment. These include blood and urine tests, biopsies, imaging (X-ray, MRI), and detection of infectious agents.Remission is a reduction or disappearance of symptoms.Exacerbation refers to the worsening of symptoms, such as increased wheezing during an asthma attack.A precipitating factor triggers an acute episode, while a...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...